Only way is up.., page-371

Hi BL,

Your post got me thinking, so I delved into previous investor presentations to jog my memory.....knowing that a nasal spray delivery system is presently in trials with MGC, I feel MMJ shareholders would like to be refreshed in the knowledge that MMJ Phytotech is in partnership with Canigma to develop a capsule based vaporiser. I think a vaporiser is an easier method of delivery for kids (and knowing exactly how difficult it is even to administer Ventolin without a space chamber for kids). Anyway, looking at the presentation again, something else caught my eye:
Check out investor presentation from July 2015 - page 5 and look for Canigma (stupid file won't upload).

A spare 2 million or so MMJ?